Conway S P, Houlsby W T
Arch Dis Child. 1986 Oct;61(10):1024-6. doi: 10.1136/adc.61.10.1024.
A double blind crossover trial with active or placebo slow release theophylline (Slo-phyllin) in children with asthma aged up to 4 years is described. Although no difference in symptom scores was shown, other differences in favour of active treatment were noted. We conclude that this preparation is of benefit in the management of the wheezing preschool child. The value of symptom scores as an index of clinical improvement is discussed.
本文描述了一项针对4岁及以下哮喘儿童的双盲交叉试验,试验中使用了活性或安慰剂缓释茶碱(Slo-phyllin)。尽管症状评分未显示出差异,但注意到了有利于活性治疗的其他差异。我们得出结论,这种制剂对喘息性学龄前儿童的治疗有益。文中还讨论了症状评分作为临床改善指标的价值。